J Breast Cancer.  2018 Jun;21(2):158-164. 10.4048/jbc.2018.21.2.158.

Interactions between Alcohol Consumption and Adjuvant Hormone Therapy in Relation to Breast Cancer-Free Survival

Affiliations
  • 1Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, USA. lyaghjyan@ufl.edu
  • 2Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA.

Abstract

PURPOSE
Alcohol consumption is associated with an increase in breast cancer risk, but findings on the association of alcohol with survival after breast cancer diagnosis have been inconsistent. Further, whether these associations could differ by adjuvant hormone therapy status is unknown. We examined interactions between alcohol consumption and adjuvant hormone therapy in relation to breast cancer-free survival among women with a primary breast cancer diagnosis.
METHODS
Participants in this study included 1,399 women diagnosed with primary breast cancer between 2007 and 2012 at the Moffitt Cancer Center. Alcohol consumption during the year preceding diagnosis was assessed in a patient survey. Information on tumor characteristics, breast cancer treatment and outcomes was available from the Moffitt Cancer Registry. Associations were examined using Cox proportional hazards models in stratified analyses by adjuvant hormone therapy status, after adjustment for potential confounders.
RESULTS
Overall, alcohol consumption was associated with significantly improved breast cancer-free survival (any vs. none: hazard ratio [HR], 0.77; 95% confidence interval [CI], 0.65-0.92). Among women without adjuvant hormone therapy, alcohol consumption was associated with better survival in heavy drinkers (HR, 0.63; 95% CI, 0.43-0.93). Among women with adjuvant hormone therapy, survival was better in women consuming alcohol as compared to nondrinkers (moderate: HR, 0.69, 95% CI, 0.51-0.93; heavy: HR, 0.74, 95% CI, 0.57-0.96; any: HR, 0.71, 95% CI, 0.57-0.87). There was no significant interaction between alcohol and adjuvant hormone therapy (p-interaction=0.54 for alcohol modeled as none or any and p=0.34 for alcohol modeled as none, moderate, and heavy).
CONCLUSION
Associations of alcohol consumption with breast cancer-free survival are similar in women with and without adjuvant hormone therapy. Future studies are warranted to elucidate potential mechanisms underlying the observed inverse associations.

Keyword

Alcohol drinking; Breast neoplasms; Disease-free survival; Proportional hazards models

MeSH Terms

Alcohol Drinking*
Breast Neoplasms
Breast*
Diagnosis
Disease-Free Survival
Female
Humans
Proportional Hazards Models

Figure

  • Figure 1 Breast cancer-free survival, by alcohol drinking status.


Reference

1. American Cancer Society. Cancer Facts & Figures 2017. Atlanta: American Cancer Society;2017.
2. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001; 286:2143–2151. PMID: 11694156.
3. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, et al. Alcohol, tobacco and breast cancer: collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002; 87:1234–1245. PMID: 12439712.
4. Kwan ML, Kushi LH, Weltzien E, Tam EK, Castillo A, Sweeney C, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010; 28:4410–4416. PMID: 20805458.
Article
5. Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, et al. Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol. 2013; 31:1939–1946. PMID: 23569314.
Article
6. Kwan ML, Chen WY, Flatt SW, Weltzien EK, Nechuta SJ, Poole EM, et al. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013; 22:32–41. PMID: 23150063.
Article
7. Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE. Effect of prediagnostic alcohol consumption on survival after breast cancer in young women. Cancer Epidemiol Biomarkers Prev. 2008; 17:1988–1996. PMID: 18664549.
Article
8. Clarke M. Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview. Ann Oncol. 2006; 17(Suppl 10):x59–x62. PMID: 17018753.
Article
9. Horn-Ross PL, Canchola AJ, Bernstein L, Clarke CA, Lacey JV Jr, Neuhausen SL, et al. Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2012; 21:2006–2013. PMID: 22832206.
Article
10. Purohit V. Can alcohol promote aromatization of androgens to estrogens? A review. Alcohol. 2000; 22:123–127. PMID: 11163119.
Article
11. Kim SK, Novak RF. The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther. 2007; 113:88–120. PMID: 17097148.
Article
12. Meskar A, Plee-Gautier E, Amet Y, Berthou F, Lucas D. Alcohol-xenobiotic interactions: role of cytochrome P450 2E1. Pathol Biol (Paris). 2001; 49:696–702. PMID: 11762131.
13. Klein DJ, Thorn CF, Desta Z, Flockhart DA, Altman RB, Klein TE. PharmGKB summary: tamoxifen pathway, pharmacokinetics. Pharmacogenet Genomics. 2013; 23:643–647. PMID: 23962908.
14. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health. 1999; 23:40–54. PMID: 10890797.
15. Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, et al. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014; 52:e65–e73. PMID: 23222531.
Article
16. U.S. Department of Health and Human Services. U.S. Department of Agriculture. Dietary Guidelines for Americans, 2005. 6th ed. Washington, DC: U.S. Government Printing Office;2005.
17. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009; 208:341–347. PMID: 19317994.
Article
18. Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014; 25:1901–1914. PMID: 24769692.
Article
19. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer;2000. p. 140–152.
20. Flatt SW, Thomson CA, Gold EB, Natarajan L, Rock CL, Al-Delaimy WK, et al. Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2010; 19:681–688. PMID: 20160253.
Article
21. Vrieling A, Buck K, Heinz J, Obi N, Benner A, Flesch-Janys D, et al. Prediagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res Treat. 2012; 136:195–207. PMID: 22961011.
Article
22. Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM. Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat. 2007; 105:195–207. PMID: 17186360.
Article
23. Allemani C, Berrino F, Krogh V, Sieri S, Pupa SM, Tagliabue E, et al. Do pre-diagnostic drinking habits influence breast cancer survival? Tumori. 2011; 97:142–148. PMID: 21617706.
Article
24. Din N, Allen IE, Satariano WA, Demb J, Braithwaite D. Alcohol consumption and mortality after breast cancer diagnosis: the health and functioning in women study. Breast Dis. 2016; 36:77–89. PMID: 27662274.
Article
25. Woods RW, Oliphant L, Shinki K, Page D, Shavlik J, Burnside E. Validation of results from knowledge discovery: mass density as a predictor of breast cancer. J Digit Imaging. 2010; 23:554–561. PMID: 19760292.
Article
26. Lowry SJ, Kapphahn K, Chlebowski R, Li CI. Alcohol use and breast cancer survival among participants in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2016; 25:1268–1273. PMID: 27197280.
Article
27. Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast cancer. Alcohol. 2005; 35:213–225. PMID: 16054983.
Article
28. Del Boca FK, Darkes J. The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction. 2003; 98(Suppl 2):1–12.
Article
29. Feunekes GI, van't Veer P, van Staveren WA, Kok FJ. Alcohol intake assessment: the sober facts. Am J Epidemiol. 1999; 150:105–112. PMID: 10400547.
Article
30. Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991; 133:810–817. PMID: 2021148.
Full Text Links
  • JBC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr